IL17A and inflammatory skin disease: Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by hyperproliferation and abnormal differentiation of keratinocytes, driven by dysregulated interactions between T cells, dendritic cells, and cytokines, such as TNF-α, IL-17, and IL-23.